Bayer sells testosterone drug rights to Grünenthal for €500m
pharmaphorum
JULY 14, 2022
Fellow German group Grünenthal is a pharma company focused mainly on pain products, although its portfolio also includes other specialty medicines such as Nexium (esomeprazole) for gastrointestinal disorders. The post Bayer sells testosterone drug rights to Grünenthal for €500m appeared first on.
Let's personalize your content